<DOC>
	<DOCNO>NCT01828138</DOCNO>
	<brief_summary>Preeclampsia ( PE ) common disorder pregnancy complicate 4-7 % pregnancy . It serious condition acute proteinuria hypertension vary degree edema 20 week gestation . PE lead severe risk low birth weight prematurity inherent complication . The pathogenesis unknown assume involve placental ischemia.The primary placental disorder result renal glomerular injury . Established PE associate paradoxical suppression renin-angiotensin-aldosterone system , RAAS . Despite suppressed RAAS , patient PE retain NaCl ( sodium chloride ) intravenous isotonic NaCl overload compare healthy pregnant woman low NaCl diet . The investigator believe data provide possible explanation overall relationship proteinuria , NaCl retension , suppression RAAS , hypertension underdevelopment placenta . Earlier data , investigator confirm , show abnormal glomerular loss enzyme plasmin/plasminogen plasma urine PE . Active plasmin urine patient nephrotic syndrome PE activate epithelial sodium channel ( ENaC ) renal collect duct cell . The investigator hypothesize loss plasmin/plasminogen share disease proteinuria , include PE , plasmin- driven ENaC ( epithelial sodium channel ) activation causal factor pathophysiology establish PE . Hyperactive ENaC cause primary renal sodium retention secondary suppression renin-angiotensin-aldosterone system . Aldosterone recently establish placental growth factor . Plasma-aldosterone level significant high normal pregnant woman . PE characterize low aldosterone level ( discovery investigator also confirm ) placental underdevelopment . Study Aim : To test specific hypothesis regard establish PE´s pathophysiological mechanism . Study Hypothesis : 1 . Excretion urine protease ( plasmin/plasminogen ) PE lead activation ENaC hence RAAS le NaCl sensitive blood pressure NaCl sensitive compare healthy pregnant woman . 2 . The degree aldosterone suppression PE determine placental development</brief_summary>
	<brief_title>Hypertension Urine Protease Activity Preeclampsia</brief_title>
	<detailed_description>Selection patient : The selection patient base outpatient preeclampsia patient normal pregnancy recruit gynecological-obstetric department , Aarhus University Hospital - Skejby , Denmark . Non- pregnant woman recruit post notice workplace . Specifically office facility , canteen gynecological department Skejby hospital , Aarhus . Background information : Registration date birth , sex , weight , height , abdominal circumference , smoke status note . Furthermore , register current antihypertensive- , diuretic- , antidiabetic- antiepileptic medicine current use medicine . Also post-partum registration gestation length , placentas weight infant weight note . Effect variable : Clinical : Weight , height , BMI , abdominal circumference . Blood pressure ( systolic , diastolic , mean arterial pressure ) . Weight placenta , gestation length , Infant weight Measurements blood test : Se-creatinine , p-Na+ , p-K+ . P-plasminogen . P-albumin . P-renin concentration ( activity ! ) , angiotensin II , aldosterone arterial natriuretic peptide ( ANP ) . Measurements 50 ml newly `` spot urine '' : Plasmin , plasminogen , ENaC peptide fragment ( analyse location development ) , Proteolytic activity , Prostatin , Creatinine , Na+ , K+ . If finding dictate may examine follow chosen urine test : - The ability activate ENaC- current M-1-collecting duct cell patch clamp electrophysiology complete cell . - Detection different proteolytic form ENaC gamma-subunit antibody . Measurements 24- hour urine sample : Na+/K+ - concentration . Creatinine clearance . Albumin . Study process : The three group , `` case '' ( patient preeclampsia ) `` pregnant control '' ( patient normal pregnancy ) non pregnant control ( non pregnant woman ) , provide 10 day healthy fully diet fix low- normal NaCl content 50 -60 mmol Na+/ day . The diet content calorie per kg body weight content potassium far possible . In period time patient must consume diet regularly drink water . Besides fixed diet patient give supplement either sodium placebo . The sequence double randomize . The participant ingest either sodium tablet ( 150-200 mmol /day ) correspond number placebo tablet . On fifth day , participant switch daily supplement , take placebo instead sodium way around . Day number 1 Monday day number 5 Friday measurement do . 24-h urine sample collect Thursday 7 a.m. till Friday morning . On 5th day participant meet 9 a.m. 10 a.m . They place chair elevate legs relaxed hour calm surroundings . From 7 a.m. ingest 200 ml water per hour . Spot urine test collect . Blood pressure measure automatic oscillometric device . Intravenous access make blood sample take decide plasma hormone concentration ( renin , angiotensin , aldosterone , ANP ) albumin , plasminogen electrolyte . Cardiac output measure non-invasive impedance cardiography . Placenta flow measure ultrasound . The procedure last approximately 2 hour . Hereafter fix , fully diet give either sodium supply , total 250 mmol/day ( correspond high average sodium intake Denmark ) placebo tablet . This diet give 4 day measurement make 5th day describe . A fixed sodium intake give : 1 . Get valid steady-state value RAAS- component ; 2 . To study reactivity RAAS component change NaCl intake 3 . Decide change blood pressure 2 different normal NaCl intake - low high normal 4 . Correlate RAAS reactivity urine excretion plasmin/plasminogen hypothesis correlation conversely 5 . Achieve valid value aldosterone correlation placenta flow . Length gestation placenta´s weight register birth . Data- analysis method : Introduction : This interventional double blind case-control , cross-over study include 10 patient preeclampsia , 10 patient normal pregnancy 10 non pregnant woman . Population size evaluation : The setting Ph.D. study make impossible accomplish fix sodium diet intervention 10 day amount patient require get relevant change blood pressure detection . With paired design estimate achieve expect change blood pressure approximately 15 mmHg individual clinical relevant different blood pressure 8 mmHg sample size must include 40 patient ( 5 % percentage point - 90 % strength ) . Therefore choose blood pressure primary variable outcome , instead choose RAAS component . In previously similar design measure hypertensive vs. normotensive patient enough statistic strength detect difference plasma concentration renin-angiotensin-aldosterone component ANP use 10 patient group .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>Cases : 1 . Pregnancy week 2836 ( exclusion patient previously severe preeclampsia ) . 2 . Singleton pregnancy 3 . Preeclampsia hypertension : repetitive high blood pressure ( &gt; 140/80 mm Hg ) measure consultation proteinuria ( dip test , albumin ) . 4 . Pregnant microalbuminuria proteinuria , without hypertension ( therefore meet diagnostic criterion preeclampsia ) also include . Proteinuria important factor . It still possible test hypothesis possible comorbidity diabetes , SLE ( systemic lupus erythematosus ) , rheumatoid arthritis therefore reason exclusion . 1 . Hypertension pregnancy without proteinuria . 2 . Pregestational nephropathy unknown reason . 3 . Early severe preeclampsia . 4 . Organic systemic disease clinical relevance , malignancy . Pregnant control 1. pregnancy week 2836 2 . Singleton pregnancy 3 . Uncomplicated pregnancy 1 . Hypertension 2 . Any kind nephropathy 3 . Organic systemic disease clinical relevance , malignancy . Nonpregnant control : 1. woman , pregnant 2 . Matched age BMI 1 . Hypertension 2 . Any kind nephropathy 3 . Organic systemic disease clinical relevance , malignancy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Proteinuria</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Plasmin</keyword>
	<keyword>Plasminogen</keyword>
	<keyword>Aldosterone</keyword>
	<keyword>Angiotensin</keyword>
	<keyword>Renin</keyword>
	<keyword>sodium chloride</keyword>
	<keyword>epithelial sodium channel</keyword>
	<keyword>Placenta</keyword>
</DOC>